• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. GYNECARE TVT SECUR SYSTEM; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. GYNECARE TVT SECUR SYSTEM; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC Back to Search Results
Catalog Number TVTS4
Device Problem Material Erosion (1214)
Patient Problems Erosion (1750); Pain (1994); Other (for use when an appropriate patient code cannot be identified) (2200); Surgical procedure (2357)
Event Type  Injury  
Event Description
It was reported by an attorney that the patient underwent a gynecological procedure on (b)(6) 2008 and a sling was implanted.It was reported that she experienced pain, erosion of her internal bodily tissue, recurrence and other injuries following the procedure.It was reported that the patient has undergone multiple surgeries and revisionary procedures.No additional information was provided.
 
Manufacturer Narrative
(b)(4).Conclusion: no conclusion can be drawn at this time.Should additional information be obtained, a supplemental 3500a form will be submitted accordingly.In addition, a review of the batch manufacturing records was conducted and the batch met all finished goods release criteria.(b)(4).Total number of events ¿ (b)(4).Gynecare tvt secur system - (b)(4).
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
(b)(4).Ethicon mdr summary reporting exemption (b)(4).Reporting period (b)(6) 2015.
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
(b)(4).Reporting period (b)(6) 2014 through (b)(4) 2015.
 
Manufacturer Narrative
Date sent to the fda: 06/20/2016.(b)(4).Reporting period december 1, 2014 through january 31, 2015.
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4).Reporting period (b)(4) 2014 through (b)(4) 2015.
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4).Reporting period (b)(4) 2014 through (b)(4) 2015.
 
Manufacturer Narrative
(b)(4).Reporting period december 1, 2014 through january 31, 2015.Supplemental 13.
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4) reporting period (b)(6) 2014 through (b)(6) 2015 supplemental 15 - attachment: [(b)(6) 2015 pah supplemental 15.Xlsx].
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4).
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4).Reporting period december 1, 2014 through january 31, 2015.
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4).Reporting period december 1, 2014 through january 31, 2015.
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4).Reporting period december 1, 2014 through january 31, 2015.
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4).Reporting period december 1, 2014 through january 31, 2015.
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4).Reporting period december 1, 2014 through january 31, 2015.
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4).Reporting period december 1, 2014 through january 31, 2015.
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4).Reporting period october 1 2014 through november 30, 2014.
 
Manufacturer Narrative
Date sent to fda: 12/27/2018.Ethicon mdr summary reporting exemption e2013037.Reporting period december 1, 2014 through january 31, 2015.
 
Manufacturer Narrative
Date sent to fda: 12/27/2018.Corrected information: marker file ¿12-31-2014 ftl supplemental 23¿ was incorrectly submitted on 10/26/2018 via manufacturer report number 2210968-2014-15475 and will be correctly submitted via 2210968-2014-12913.
 
Manufacturer Narrative
Date sent to fda: 2/12/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period december 1, 2014 through january 31, 2015.
 
Manufacturer Narrative
Date sent to fda: 04/24/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period december 1, 2014 through january 31, 2015.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GYNECARE TVT SECUR SYSTEM
Type of Device
MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876 0151
Manufacturer (Section G)
ETHICON SARL-NEUCHATEL
puits-godet 20 2000 neuchatel
neuchatel
SZ  
Manufacturer Contact
guillermo villa
route 22 west po box 151
somerville, NJ 08876
9082180707
MDR Report Key4545671
MDR Text Key5510536
Report Number2210968-2014-15475
Device Sequence Number1
Product Code PAH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K052401
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,other
Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 06/20/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/25/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/31/2009
Device Catalogue NumberTVTS4
Device Lot Number3101579
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Date Manufacturer Received04/24/2019
Was Device Evaluated by Manufacturer? No
Date Device Manufactured11/27/2007
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age49 YR
Patient Weight75
-
-